sequence (b) Search Results


micb  (Boster Bio)
91
Boster Bio micb
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Micb, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/pmc08924122-38-5-7?v=Boster+Bio
Average 91 stars, based on 1 article reviews
micb - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier
anti-drosha sirna1 , 5′-cgaguaggcuucgugacuu(dtdt)-3′  (B-Bridge Inc)
90
B-Bridge Inc anti-drosha sirna1 , 5′-cgaguaggcuucgugacuu(dtdt)-3′
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Anti Drosha Sirna1 , 5′ Cgaguaggcuucgugacuu(dtdt) 3′, supplied by B-Bridge Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/pmc03519575-276-8-9?v=B-Bridge+Inc
Average 90 stars, based on 1 article reviews
anti-drosha sirna1 , 5′-cgaguaggcuucgugacuu(dtdt)-3′ - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
kif18b sequence b peptide  (Biomatik)
90
Biomatik kif18b sequence b peptide
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Kif18b Sequence B Peptide, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/pm34192545-168-188-193?v=Biomatik
Average 90 stars, based on 1 article reviews
kif18b sequence b peptide - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
shrew-1 sequence a fwd., 5′-gatccg cacatttccgggcgtttac ttcaagaga gtaaacgcccggaaatgtg ttttttggaaa-3′  (MWG-Biotech ag)
90
MWG-Biotech ag shrew-1 sequence a fwd., 5′-gatccg cacatttccgggcgtttac ttcaagaga gtaaacgcccggaaatgtg ttttttggaaa-3′
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Shrew 1 Sequence A Fwd., 5′ Gatccg Cacatttccgggcgtttac Ttcaagaga Gtaaacgcccggaaatgtg Ttttttggaaa 3′, supplied by MWG-Biotech ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/pmc01838978-60-20-9?v=MWG-Biotech+ag
Average 90 stars, based on 1 article reviews
shrew-1 sequence a fwd., 5′-gatccg cacatttccgggcgtttac ttcaagaga gtaaacgcccggaaatgtg ttttttggaaa-3′ - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
genome sequence b. animalis subsp. lactis hn019  (NCIMB Ltd)
90
NCIMB Ltd genome sequence b. animalis subsp. lactis hn019
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Genome Sequence B. Animalis Subsp. Lactis Hn019, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/10__1128_slash_jb__01555___09-203-57-55?v=NCIMB+Ltd
Average 90 stars, based on 1 article reviews
genome sequence b. animalis subsp. lactis hn019 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
flip-angle sequence b 1 -map  (Siemens AG)
90
Siemens AG flip-angle sequence b 1 -map
<t>MICA/B</t> release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and <t>MICB</t> concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.
Flip Angle Sequence B 1 Map, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+%28b%29/pmc07116593-136-8-12?v=Siemens+AG
Average 90 stars, based on 1 article reviews
flip-angle sequence b 1 -map - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human mhc class i polypeptide-related sequence b elisa kit  (Innovative Research Inc)
N/A
This Human MHC Class I Polypeptide-Related Sequence B ELISA Kit from Innovative Research is intended for quantitative detection of human MICB in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). Strip well format.
   Buy from Supplier
human mhc class i polypeptide-related sequence b  (Shanghai Korain Biotech Co Ltd)
N/A
Seems to have no role in antigen presentation. Acts as a stress-induced self-antigen that is recognized by gamma delta T cells. Ligand for the KLRK1/NKG2D receptor. Binding to KLRK1 leads to cell lysis.
   Buy from Supplier
human mhc class i polypeptide-related sequence b(micb) elisa kit  (Cusabio)
N/A
Human MHC class I polypeptide-related sequence B(MICB) ELISA kit
   Buy from Supplier
recombinant human mhc class i polypeptide-related sequence b  (Creative BioMart)
N/A
Recombinant HumanMICB has 326 amino acid residues containing the extracellular domain ofmature human MICB (amino acid residues Ala23-Tyr312).This gene encodes aheavily glycosylated protein which is a ligand for the NKG2D type IIreceptor. Binding of the
   Buy from Supplier
human mhc class i polypeptide related sequence b (micb) elisa kit  (Bioss)
N/A
   Buy from Supplier

Image Search Results


MICA/B release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and MICB concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells

doi: 10.3389/fcell.2022.829404

Figure Lengend Snippet: MICA/B release is increased from senescent cells. (A) SH-SY5Y cells were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, cellular senescence was evaluated by SA-β-gal staining. Senescent cells are shown by blue staining (magnification: ×20). (B) Cell cycle progression was assessed by flow cytometry. (C) Four different neuroblastoma cell lines were treated with 2 μM MLN8237, 0.5 μM DOX, DMSO, or no treatment as a control, and after 72 h, (D) MICA and MICB concentrations in the supernatant were evaluated by ELISA. Data represent the mean ± SEM of three independent experiments. * p < 0.05.

Article Snippet: The MICA(1:100, EK0812-CAP, BOSTER) or MICB(1:100, EK0963-CAP, BOSTER) monoclonal antibody was then added and incubated for another 1 h at 37°C, followed by washing the cells three times with TBS, addition of the diluted peroxidase complex, and incubation at 37°C for 30 min. After washing five times, 3,3′,5,5′-tetramethylbenzidine luminescent substrate was added, and color development was performed for 30 min.

Techniques: Control, Staining, Flow Cytometry, Enzyme-linked Immunosorbent Assay

GI254023X combination chemotherapy reduces MICA/B secretion and enhances NK cell recognition. IMR-32 cells were induced to senescence by treatment with MLN8237 or DOX, followed by addition of the ADAM10 inhibitor GI254023X (5 µM) for 72 h. The expression of (A) MICA and (B) MICB in the supernatant was detected by ELISA. (C) Cell-surface expression of MICA/B was detected by flow cytometry following the described treatments. (D) Cells in the different treatment groups were used as target cells, and normal human peripheral blood NK cells were used as effector cells. Killing efficiency was detected by the calcein-AM method in co-cultures at effector:target cell ratios of 5:1,10:1, and 20:1 for 4 h. Data represent the mean ± SEM of three independent experiments. * p < 0.05.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells

doi: 10.3389/fcell.2022.829404

Figure Lengend Snippet: GI254023X combination chemotherapy reduces MICA/B secretion and enhances NK cell recognition. IMR-32 cells were induced to senescence by treatment with MLN8237 or DOX, followed by addition of the ADAM10 inhibitor GI254023X (5 µM) for 72 h. The expression of (A) MICA and (B) MICB in the supernatant was detected by ELISA. (C) Cell-surface expression of MICA/B was detected by flow cytometry following the described treatments. (D) Cells in the different treatment groups were used as target cells, and normal human peripheral blood NK cells were used as effector cells. Killing efficiency was detected by the calcein-AM method in co-cultures at effector:target cell ratios of 5:1,10:1, and 20:1 for 4 h. Data represent the mean ± SEM of three independent experiments. * p < 0.05.

Article Snippet: The MICA(1:100, EK0812-CAP, BOSTER) or MICB(1:100, EK0963-CAP, BOSTER) monoclonal antibody was then added and incubated for another 1 h at 37°C, followed by washing the cells three times with TBS, addition of the diluted peroxidase complex, and incubation at 37°C for 30 min. After washing five times, 3,3′,5,5′-tetramethylbenzidine luminescent substrate was added, and color development was performed for 30 min.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Flow Cytometry